Stocks
Roche Holding (RHHBY) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, ₣ | ? | 22 188 000 000 | 24 072 000 000 | 18 413 000 000 | 16 619 000 000 | 21 705 000 000 | 38 324 000 000 | ||
| Changes by years, y/y, % | -3% | +8% | -24% | -10% | +31% | -1.1% | |||
Roche Holding. EBITDA US GAAP, ₣
Roche Holding. EBITDA US GAAP, changes, %
Roche Holding. EBITDA US GAAP, sum by quarters, ₣
Roche Holding (RHHBY) EBITDA US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q2 | FY2024Q4 | FY2025Q2 | FY2025Q4 | LTM ? | |||
| EBITDA, ₣ | ? | 7 070 000 000 | 10 530 000 000 | 6 089 000 000 | 6 525 500 000 | 15 179 500 000 | 38 324 000 000 | |
| Changes by years, y/y, % | -30% | -7% | -14% | -38% | +149% | |||
| Changes by quarters, q/q, % | -38% | +49% | -42% | +7% | +133% | |||
